Fig. 4From: Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitusDiscriminative performance of the ESC/EASD risk model, NT-proBNP and SCORE in the overall cohort in T2DM individuals without CVD and without CVD aged 40–64 years for the outcome (a) cardiovascular (CV) death and (b) all-cause death. The figure displays C-indices and 95% confidence intervals (CI)Back to article page